Clinical Significance of Breast Cancer Molecular Subtypes and Ki67 Expression as a Predictive Value for Pathological Complete Response following Neoadjuvant Chemotherapy: Experience from a Tertiary Care Center in Lebanon
Introduction. Breast cancer is considered nowadays the most prevalent cancer worldwide. The molecular era has successfully divided breast cancer into subtypes based on the various hormonal receptors. These molecular subtypes play a major role in determining the neoadjuvant chemotherapy to be adminis...
Saved in:
| Main Authors: | Ali Atoui, Maroun Bou Zerdan, Ahmad El Mahmoud, Nathalie Chamseddine, Lina Hamad, Hazem I. Assi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | International Journal of Breast Cancer |
| Online Access: | http://dx.doi.org/10.1155/2022/1218128 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Impact of Tumor Infiltrating Lymphocytes Densities and Ki67 Index on Residual Breast Cancer Burden following Neoadjuvant Chemotherapy
by: Aya Elmahs, et al.
Published: (2022-01-01) -
The association between Ki-67 expression and survival in breast cancer subtypes: a cross-sectional study of Ki-67 cut-point in northern Thailand
by: Phanchaporn Wongmaneerung, et al.
Published: (2025-02-01) -
Predictive factors for complete pathologic response in luminal breast cancer: impact of ki67 and HER2 low expression
by: Isabel Miras, et al.
Published: (2024-12-01) -
Integrating traditional biomarkers and emerging predictors to assess neoadjuvant chemotherapy efficacy in breast cancer: a multifactorial analysis of Ki-67, CDK4, EGFR, TILs and ctDNA
by: Tianzhao Du, et al.
Published: (2024-12-01) -
Analysis of tumor cell proliferation (Ki-67) and cell cycle regulator proteins in lung adenocarcinoma with different radiological subtypes
by: Rirong Qu, et al.
Published: (2025-04-01)